Your Shopping Cart
By using this site you agree to our use of cookies. Please refer to our privacy policy for more information. Close
Hello. Sign In
Your Account

Log In to ComplianceOnline
Welcome back! Please log in below to continue.
0
Cart
Toll Free:
+1-888-717-2436
+1-888-717-2436
Industries
- Banking & Financial Services
- BANKING & FINANCIAL SERVICES
- Banks and Credit Unions
- Financial Services and Trading
- Insurance
- Accounting and Taxation
- Life Sciences
- Hitech, Aero & Manufacturing
- HITECH, AERO & MANUFACTURING
- Quality & Safety
- Standards and Methodology
- Energy & Utilities
- ENERGY & UTILITIES
- IT Security
- Reliability (NERC / FERC)
- Quality and Safety
- Risk Management
- CPG & Retail
- CPG & RETAIL
- Retail Audit
- Quality & Safety
- Social Compliance
- Healthcare
- Food & Dietary Supplements
- Cross Industry Functions
Webinars
By Industries
Seminars
The Drug Development Process from Concept to Market
Analytical Instrument Qualification and System Validation
Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)
HIPAA Privacy Rule Compliance-Understanding New Rules and Responsibilities of Privacy Officer
Biocompatibility Testing: What You Need to Know
Navigating the Medical Device Post-Market Maze and Challenges ...
Coping with FDA Import Delays, including COVID-19, Expedited Imports and Detentions
The Veterinary Drug Approval Process and FDA Regulatory Oversight
Regulatory Compliance for Dietary Supplements in the US, EU and Canada
Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
Standards
Aerospace
Agriculture and Farm Machinery
Automotive, Aircraft & Marine technology
Banking, Corp. finance & Sox
Biotech & Pharmaceutical Standards
Chemical technology
Civil engineering and construction
Computer Hardware
Electrical Engineering
Electronic Equipment
ANSI
Audit Net
BIN
BPA
Business Basics
Complianceonline
IT Governance
LabCompliance
Quality-Control-Plan
RCGLOBAL
SHOQ Quality Assurance Manuals
SEPT
Home
› Best Practices
NIH and FDA Team Up to Initiate Fast-track Innovations to Speed New Treatments to Patients
- Date: March 11, 2010
- Source: admin
What could have been better? The U.S. Food and Drug Administration (FDA) has teamed up with National Institute of Health (NIH) to pace up the process from scientific breakthrough to launch in market new and innovative medical therapies for patients.
The initiative started by FDA and NIH engages two interrelated scientific disciplines:
- Translational science, which deals with the shaping of basic scientific discoveries into treatments; and
- Regulatory science, which deals with the development and use of new tools, standards and approaches to more proficiently develop products and to more efficiently evaluate safety, efficacy and quality of products.
In both of these disciplines, biomedical discoveries will turn into products that benefit people.
Establishing Joint NIH-FDA Leadership Council
This initiative includes establishment of a Joint NIH-FDA Leadership Council. This council will organize joint action of the two organizations on important public health issue and will work hand in hand to ensure that regulatory considerations form an integral component of biomedical research planning, and that the newest science is included into the regulatory review process.
Additionally, the NIH and the FDA have planned to jointly issue a Request for Applications, making $6.75 million dollars available over three years for work in regulatory science.
According to the HHS Secretary Kathleen Sebelius, “Collaboration between NIH and FDA, including support for regulatory science, will go a long way towards fostering access to the safest and most effective therapies for the American people."
Impact of this Initiation
This joint venture will combine NIH’s vast experience supporting and facilitating new discoveries in the laboratory and clinic with the FDA’s more than 100 years of experience and knowledge in the regulation and approval of drugs, biologics and medical devices. Therefore, hope of common people to receive fast paced yet quality medicine can safely get a boost.
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs believes "The FDA plays an essential and unique role in how therapies are evaluated. We are the bridge between biomedical research discoveries and new medical products…We now have a special opportunity--and responsibility--to harness advances in science and technology to support our efforts. We are working in collaboration with the best minds and research institutions available, so that we can better develop and utilize new tools, standards and approaches needed to properly assess the safety, effectiveness and quality of products currently in development or already on the market."
However, The FDA and the NIH will hold a public meeting in the spring to solicit input on how the agencies can work better together.
Source:
http://www.fda.gov/
Compliance Trainings

Pregnancy in the Workplace: Strategies to Protect Your Organization from Pregnancy Discrimination Claims
By - Christopher W. Olmsted
On Demand Access Anytime
By - Christopher W. Olmsted
On Demand Access Anytime

How to Vet an IRB: Expose and Fix Problems Before They Threaten Your Trial
By - Madhavi Diwanji
On Demand Access Anytime
By - Madhavi Diwanji
On Demand Access Anytime

Compliance Standards
Best Sellers
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
By: Miles HutchinsonAdd to CartPrice: $249
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
-
San Francisco, CA | Aug 6-7, 2020
-
Virtual Seminar | Jul 16-17, 2020
-
Virtual Seminar | Jun 18-19, 2020
-
Los Angeles, CA | Aug 20-21, 2020
-
Virtual Seminar | Jul 16-17, 2020
-
Virtual Seminar | Jun 25-26, 2020
-
Virtual Seminar | Jun 10, 2020
-
Virtual Seminar | Jun 3-4, 2020
-
Virtual Seminar | Jul 6-7, 2020
-
San Francisco, CA | Oct 22-23, 2020
-
Virtual Seminar | Jul 9-10, 2020
-
Virtual Seminar | Jun 3-4, 2020
-
Virtual Seminar | June 3-4, 2020
-
Miami, FL | Jul 29-31, 2020
-
Virtual Seminar | Jun 17, 2020
-
Provider: ANSIAdd to CartPrice: $142
- Add to Cart
- Add to Cart
- Add to Cart
-
Provider: ANSIAdd to CartPrice: $120
-
Provider: ANSIAdd to CartPrice: $250
-
Provider: SEPTAdd to CartPrice: $299
- Add to Cart
-
Provider: Quality-Control-PlanAdd to CartPrice: $37
- Add to Cart
-
Provider: At-PQCAdd to CartPrice: $397
- Add to Cart
- Add to Cart
- Add to Cart
- Add to Cart
You Recently Viewed
